Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE provisionally rejects Ipsen’s kidney cancer drug Cabometyx

February 21, 2017
Manufacturing and Production, Sales and Marketing Cometriq, NICE, ipsen

NICE has announced draft guidance for Ipsen’s cancer drug Cabometyx (cabozantinib), revealing it does not recommend the drug for use on …

News
takeda

Faulty batch of Takeda’s paracetamol discovered in Denmark

February 21, 2017
Manufacturing and Production Denmark, Takeda

Takeda has announced a recall of a batch of its paracetamol tablets, named Pamol, in Denmark after two packs were …

News
mr058666-web

Merck eyes new India bio-production facility

February 21, 2017
Manufacturing and Production Merck

German pharmaceutical firm Merck has made it known that it has plans to expand its operations in India with a …

News
handshake

Amygdala acquires Gilead’s candidate for addiction treatment

February 20, 2017
Manufacturing and Production, Sales and Marketing Amygdala, Gilead

Amygdala Neurosciences, a biopharmaceutical company that develops and commercialises drugs for the treatment of addiction disorders, has agreed an acquisition …

News

BlackThorn Therapeutics bring in new CEO

February 20, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BlackThorn Therapeutics

BlackThorn Therapeutics, a biopharmaceutical company that works on developing treatments for neurobehavioral disorders, announced the appointment of Gregory Vontz to …

Appointment
medication

Generic version of top-selling lung cancer drug hits Chinese market

February 20, 2017
Sales and Marketing China, generics

A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the Chinese market, named Yiruike. The generic undercuts the …

News
celgene_1_02

Celgene’s potential blockbuster gets positive Phase 3 results in multiple sclerosis

February 20, 2017
Research and Development, Sales and Marketing Celgene, multiple sclerosis

Celgene’s drug to treat patients suffering with relapsing multiple sclerosis (RMS) was given a boost by positive Phase 3 trial …

News
heart_image

Cardiovascular disease expected to place $1 trillion cost burden on US

February 20, 2017
Medical Communications, Sales and Marketing cardiovascular disease

A study conducted by RTI International, a non-profit research institute, has warned that the US could have to balance over …

News
astrazeneca_logo_building

AstraZeneca sells off cancer drug to TerSera for $250 million

February 20, 2017
Sales and Marketing AstraZeneca, TerSera Therapeutics, Zoladex

AstraZeneca announced that it has sold Zoladex’s (goserelin acetate implant) commercial rights in the US and Canada to TerSera Therapeutics. …

News
hospital_ward

Rise of superbugs in hospitals down to cutting cleaners’ jobs, suggests GMB

February 20, 2017
Sales and Marketing GMB, MRSA, NHS, Superbugs

The rising numbers in those exposed to superbugs, such as E.coli and MRSA, is due to the cuts in the …

News
novartis_appointment

New Managing Director of UK & Ireland for Novartis

February 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis

Novartis announced the appointment of Haseeb Ahmad as Managing Director for UK & Ireland. He joins from MSD, known as …

Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Stories have erupted out of the industry this week with leaps forward in malaria and cancer R&D, some controversial drug …

News
pills

The future of generic drugs and strategies for commercial success

February 17, 2017
Medical Communications generics

GBI Research examines whether the US continue to dominate the global generic drug market.

News

Zydus Cadila scores twin FDA approvals

February 17, 2017
Medical Communications, Sales and Marketing FDA, Zydus Cadila

Indian pharmaceutical firm Zydus Cadila has announced that the US Food and Drug Administration (FDA) has given the go-ahead for …

News
astrazeneca_logo_building

AstraZeneca’s drug scores positive results against chemo in breast cancer

February 17, 2017
Medical Communications, Research and Development AstraZeneca

AstraZeneca announced that its drug, Lynpara (olaparib), had positive results for a recent Phase 3 trial when tested against standard …

News
takeda_tokyo_hq

Takeda and TiGenix announce successful trial of Crohn’s disease drug

February 17, 2017
Medical Communications, Sales and Marketing Takeda, TiGenix

Takeda and TiGenix announced Phase 3 results from a trial looking into the investigational compound Cx601, a treatment for refractory …

News
donald_trump_september_3_2015

What does Trump’s victory mean for the pharma, biotech and healthcare sectors?

February 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Trump

After his first month in office and numerous threats to big pharma, finnCap Life Sciences analysts Alex Pye and Mark …

Feature
abbvie_0

NICE rejects AbbVie’s leukaemia drug

February 16, 2017
Sales and Marketing AbbVie

NICE has rejected AbbVie Venclyxto (venetoclax) for the treatment of chronic lymphocytic leukmaemia, on various grounds but primarily focusing upon …

News
mosquito

Malaria vaccine displays 100% success rate in clinical trial

February 16, 2017
Research and Development Vaccine, malaria

A malaria vaccine, jointly developed by the University of Tübingen and biotech company Sanaria Inc., has demonstrated in a small pool …

News
facilities_lg06

Dr Reddy’s rocked by negative patent infringement ruling, shares hit one-year low

February 16, 2017
Sales and Marketing Dr Reddy's Laboratories, Helsinn Healthcare

India-based pharmaceutical firm Dr Reddy’s Laboratories has been hit by an unfavourable ruling in a legal case claiming it infringed …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026